Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan

IMPORTANCE: Financial relationships between pharmaceutical companies and physicians can bias the conduct, findings, and reporting of clinical trials. In Japan, the valsartan scandal was a significant event: all 5 key articles on the valsartan clinical trials were retracted after the revelation of da...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawano, Toyoaki, Ozaki, Akihiko, Saito, Hiroaki, Shimada, Yuki, Tanimoto, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537813/
https://www.ncbi.nlm.nih.gov/pubmed/31099864
http://dx.doi.org/10.1001/jamanetworkopen.2019.3817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537813/
https://www.ncbi.nlm.nih.gov/pubmed/31099864
http://dx.doi.org/10.1001/jamanetworkopen.2019.3817

Ejemplares similares